1-5 of 5
Artur Veloso
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas

Michael S. Nakazawa, Ian M. Silverman, Victoria Rimkunas, Artur Veloso, Dominik Glodzik, Adrienne Johnson, Toshiro K. Ohsumi, Shreyaskumar R. Patel, Anthony P. Conley, Christina L. Roland, Pamela T. Soliman, Hannah C. Beird, Chia-Chin Wu, Davis R. Ingram, Rossana Lazcano, Dawon Song, Khalida M. Wani, Alexander J. Lazar, Timothy A. Yap, Wei-Lien Wang, J. Andrew Livingston
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (7): 1057–1065.
https://doi.org/10.1158/1535-7163.MCT-23-0761
Published: 02 July 2024
View article titled, Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas
Open the PDF for Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas in another window
Includes: Supplementary data
Journal Articles

Abstract A017: Characterizing intratumoral heterogeneity of CCNE1 amplification in ovarian cancer using digital pathology

Adam Petrone, Isabel Soria-Bretones, Adrienne Johnson, Sunantha Sethuraman, Ian M Silverman, Jorge Reis-Filho, Gary Marshall, Artur Veloso, Elia Aguado-Fraile, Victoria Rimkunas
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (6_Supplement): A017.
https://doi.org/10.1158/1538-8514.SYNTHLETH24-A017
Published: 10 June 2024
View article titled, Abstract A017: Characterizing intratumoral heterogeneity of <em>CCNE1</em> amplification in ovarian cancer using digital pathology
Journal Articles

Abstract C163: KRAS alterations combined with TP53 mutations as novel synthetic lethal genomic lesions for PKMYT1 inhibition

Marc L. Hyer, Jimmy Fourtounis, David Gallo, Vivek Bhaskaran, Rino Stocco, Rosie Kryczka, Sai Save, Helen Burston, Olivier Nicolas, Stephen Morris, Anne Roulston, Jordan T. F. Young, Michal Zimmermann, C. Gary Marshall, Artur Veloso, Elia Aguado-Fraile
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): C163.
https://doi.org/10.1158/1535-7163.TARG-23-C163
Published: 01 December 2023
View article titled, Abstract C163: KRAS alterations combined with TP53 mutations as novel synthetic lethal genomic lesions for PKMYT1 inhibition
Journal Articles

RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors

Anne Roulston, Michal Zimmermann, Robert Papp, Alexander Skeldon, Charles Pellerin, Émilie Dumas-Bérube, Valerie Dumais, Stéphane Dorich, Lee D. Fader, Sara Fournier, Li Li, Marie-Eve Leclaire, Shou Yun Yin, Amandine Chefson, Hunain Alam, William Yang, Chloe Fugère-Desjardins, Sabrina Vignini-Hammond, Kathryn Skorey, Amina Mulani, Victoria Rimkunas, Artur Veloso, Martine Hamel, Rino Stocco, Yael Mamane, Zuomei Li, Jordan T.F. Young, Michael Zinda, W. Cameron Black
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (2): 245–256.
https://doi.org/10.1158/1535-7163.MCT-21-0615
Published: 01 February 2022
View article titled, RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
Open the PDF for RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract P054: RP-3500: A novel, potent and selective ATR inhibitor that is effective in pre-clinical models as a monotherapy and in combination with PARP inhibitors

Anne Roulston, Michal Zimmerman, Robert Papp, Alex Skeldon, Charles Pellerin, Émilie Dumas-Bérube, Valerie Dumais, Stephane Dorich, Sara Fournier, Li Li, Marie-Ève Leclaire, Shou Yun Yin, Amandine Chefson, Hunain Alam, William Yang, Chloe Fugère-Desjardins, Sabrina Hammond, Kathryn Skorey, Amina Mulani, Victoria Rimkunas, Artur Veloso, Martine Hamel, Rino Stocco, Yael Mamane, Zuomei Li, Jordan Young, Mike Zinda, Cameron Black
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P054.
https://doi.org/10.1158/1535-7163.TARG-21-P054
Published: 01 December 2021
View article titled, Abstract P054: RP-3500: A novel, potent and selective ATR inhibitor that is effective in pre-clinical models as a monotherapy and in combination with PARP inhibitors